AstraZeneca in Shanghai (Shutterstock)
October 30, 2024 11:15 AM EDTUpdated 01:25 PM
China
Law

As­traZeneca Chi­na ex­ec probed by lo­cal au­thor­i­ties

Ayisha Sharma

News Reporter

As­traZeneca said Wednes­day its Chi­na pres­i­dent Leon Wang is un­der in­ves­ti­ga­tion in the coun­try, days af­ter it was re­port­ed a BeiGene …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times